TrialFrontiers in immunology2022

Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency.

Bob Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.